CIK 0001650648
- Non-accelerated filer
- Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473506994
- Phone
- +1 510-505-2680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,616,428
- in 5 filings, $1.6M under 10b5-1 plans
Net −$1,616,428. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-16 | Bizily Scott Chief Legal Officer | Exercise or conversion 10b5-1 | +1,635 | $4.14 | $7K | 10,252 |
| 2026-10-16 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,635 | $12.84 | $21K | 8,617 |
| 2026-10-16 | Bizily Scott Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −1,635 | 56,431 | ||
| 2026-09-16 | Bizily Scott Chief Legal Officer | Exercise or conversion 10b5-1 | +1,635 | $4.14 | $7K | 10,252 |
| 2026-09-16 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,635 | $13.65 | $22K | 8,617 |
| 2026-09-16 | Bizily Scott Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −1,635 | 58,066 | ||
| 2026-09-01 | Bizily Scott Chief Legal Officer | Exercise or conversion 10b5-1 | +584 | $6.49 | $4K | 9,201 |
| 2026-09-01 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −584 | $14.00 | $8K | 8,617 |
| 2026-09-01 | Bizily Scott Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −584 | 2,959 | ||
| 2026-08-17 | Bizily Scott Chief Legal Officer | Exercise or conversion 10b5-1 | +1,635 | $4.14 | $7K | 10,252 |
| 2026-08-17 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,635 | $12.20 | $20K | 8,617 |
| 2026-08-17 | Bizily Scott Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −1,635 | 59,701 | ||
| 2026-08-13 | Bizily Scott Chief Legal Officer | Exercise or conversion 10b5-1 | +1,635 | $4.14 | $7K | 10,252 |
| 2026-08-13 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −1,635 | $12.00 | $20K | 8,617 |
| 2026-08-13 | Bizily Scott Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −1,635 | 61,336 | ||
| 2026-06-30 | Bizily Scott Chief Legal Officer | Exercise or conversion 10b5-1 | +814 | $4.14 | $3K | 9,431 |
| 2026-06-30 | Bizily Scott Chief Legal Officer | Exercise or conversion 10b5-1 | +5,752 | $6.49 | $37K | 15,183 |
| 2026-06-30 | Bizily Scott Chief Legal Officer | Sale 10b5-1 | −6,566 | $14.00 | $92K | 8,617 |
| 2026-06-30 | Bizily Scott Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −814 | 62,971 | ||
| 2026-06-30 | Bizily Scott Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,752 | 3,543 |
Page 1 of 7 · 139 trades